Report me for selling fake medicine? Why are you crying when your illness relapses?

On the one hand, my body can’t take it, and on the other hand, there are too many temptations from the outside world.

After achieving world-class results, life will indeed be subject to various temptations, and very few people can stick to their original aspirations.

Chen Xuan is one of them. Not only can he stick to his original intention, but he can also devote his wholehearted and greatest energy and never stop because of his achievements.

This also made Anna unconsciously develop great respect for him.

"Mr. Chen, have you heard of Elsilan?"

At this time, Anna suddenly asked again.

She looked at Chen Xuan's face, wondering what his answer would be.

"I know. There's been a lot of talk lately about the company Pfizer wants to acquire."

"No matter how ignorant I am, there is no way I haven't heard of this matter, but why did you suddenly mention it?"

Chen Xuan answered casually, not showing much concern about the matter.

In fact, this matter was not very important to him. Elsilan posed no threat to him.

"Yes, Pfizer does want to acquire Elsilan."

"Based on Pfizer's recent investigation, the acquisition is almost certain."

"Also, thanks to this acquisition, Pfizer's stock price has risen significantly recently, as the market is optimistic about Alciran's anti-cancer drug project."

Anna spoke out about this.

She said this now to remind Chen Xuan.

Pfizer will inevitably become a rival to Aetna Pharmaceuticals, especially given the recent relationship between the two, which makes it more likely that they will become enemies.

That's why she specifically reminded him and wanted to know his attitude towards this matter.

However, Chen Xuan's expression remained extremely calm.

My mood is also calm.

The main reason is that he had already ended his short selling on Pfizer, and the profits had long been returned to his wallet, so it didn't matter whether the stock price went up or not. Even if it went up wildly, it had nothing to do with him.

Of course, Pfizer has only confirmed the acquisition and has not officially completed it, but the stock price has risen a lot. It seems that the market is indeed very optimistic about this project.

"Pfizer's acquisition price should be between $80 billion and $100 billion."

"Mr. Chen, do you think this anti-cancer project is worth acquiring? If you were the decision-maker at Pfizer, would you agree to the acquisition?"

Anna asked again, "Or, if you were the head of the Elsilan company, would you sell the anti-cancer drug project for this price?"

She just wanted to know whether this anti-cancer drug project was really that valuable?

A $100 billion acquisition is a relatively rare acquisition, and one that Novartis takes very seriously.

However, she was unable to analyze the benefits and risks of this project for the time being, so she wanted to get some judgment from Chen Xuan.

The latter analysis may not be correct, but it is certainly of great reference value, which is why she asked this question.

This is not just curiosity, but also from a business perspective.

If the project is extremely profitable, Novartis will also consider competing with Pfizer.

"I'm not Pfizer, so I can't judge whether this project is worthwhile."

"After all, I don't really understand this project. Maybe Pfizer has more detailed information to make a judgment."

"But if I were Pfizer and were in charge of this project, I probably wouldn't acquire it. The risk is too great and I don't think it's worth it."

Chen Xuan said with a puzzled expression, "But if I were on the Elsilan side, I would sell this formula without hesitation, the sooner the better, and get the money as much as possible."

Chen Xuan was still extremely surprised by the $100 billion acquisition.

But after thinking about it, I realized that this is an anti-cancer drug project, and it has entered the third phase of clinical trials, and the clinical performance is very ideal.